At carefully curated interactive stations, Takeda experts will present their efforts and projects in the three focus areas of the event – sustainability, digital acceleration, and biotherapeutics processing tools – and answer any questions from the participants. Among some of the elements featured will be Process Analytical Technology (PAT) tools, advanced processing, and modularization and automation of processes. Participants will also discover how Takeda employs AI and how its laboratories manage to reduce their carbon footprint without compromising research quality and safety.
Program overview:
14:00 doors open & registration
14:30 the official program starts. First there will be a presentation about Takeda and its R&D organization. This will be followed by a presentation on the three key themes of digital acceleration, bioprocessing and sustainability.
15:30 guests can visit Takeda's booths and talk to the company's experts. This is a great opportunity to share ideas and lay the foundation for future collaborations.
17:30 Networking and snacks: guests are welcome to stay and network with the Takeda teams over drinks and snacks.
The number of participants is limited to 60 and registration for this event is done on a first come, first served basis.
To register for the event, contact RnD.Austria(at)takeda.com and submit a short description of your company, organization, institute or technology you’ve developed or are working on. A confirmation of your participation will be sent until November 10th.
For questions about the event, don’t hesitate to reach out to Larissa Kahr (Takeda Head, External Partnerships Interface Europe) larissa.kahr(at)takeda.com or Elvira Kainersdorfer (LISAvienna, Technology Expert Life Sciences) kainersdorfer(at)lisavienna.at.
We are looking forward to welcoming you!
Thu, 23.11.2023 | 14:00 - 18:30 h
ARIANA Event Hall
Christine-Touaillon Straße 4
1220 Vienna
Austria
About Takeda:
Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries. For more information, visit www.takeda.com.